× We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click our cookies policy for information on how to change your cookie settings.


× Important note: Due to the end of funding, these reviews are no longer in living mode. We try to update them on a monthly basis.

meta|Evidence - COVID-19

Living meta-analysis and evidence synthesis of therapies for COVID19  

Member of the meta|Evidence galaxy

tutorial video
En     Fr

Our approach

RSS

       
button bars forest bayes pooled summary circles
Treament Trials   auto
deathsclinical improvementdeath or ventilation
0---
7 / 16 -8% certainty unassessable-27%
1 certainty unassessable+10% certainty unassessable+23%-
11 / 18 -9%+16%-
1 / 2 certainty unassessable-42% certainty unassessable+187%-
1 / 2 --
0---
0---
4 / 5 -38%+40%-
8 / 18 safety concern-6%statistically conclusive+44%-4%
3 / 6 +9% certainty unassessable+3%-
2 certainty unassessable+8% certainty unassessable-16%-
1 certainty unassessable+9%--

Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant

149
treatments 		  718
studies with results 		  1743
studies screend 		  1629
references

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

     

- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons